Eligibility: All NGI-affiliated faculty members are eligible to apply, and we encourage applications from both new investigators and established PIs who are interested in transitioning from animal or cell models to human data. The Project PI must be a member as of the submission deadline. Learn more about membership.

How to apply: Letters of intent (LOIs) may be submitted by affiliated members of the NeuroGenomics and Informatics Center.

Please download and complete the LOI application form linked here. LOIs must be returned by email to neurogenomics@wustl.edu by 5:00pm CST on Friday, December 9, 2022. Complete LOIs must include answered questionnaire, brief project summary, specific aims, NIH style biosketch(s) and other support for the PI(s).

Selected LOIs will be announced by Friday December 23, 2022 and invited to submit a full proposal by Friday February 3, 2023. The full submission must include: a technical abstract (250 words, which will be made public in case of project being awarded), specific aims (1 page maximum), research plan (5 pages maximum), references, detailed budget and budget justification, and biosketch(s) and other support for the PI(s).

Funding announcements will be the week of March 20, 2023. Selected proposals will receive up to $100,000 for a one-year project period for collaborative projects or up to $50,000 for an individual project. The project funding period is April 1, 2023 through March 31, 2024.

Timeline:

  • December 9, 2022            LOIs due by 5:00pm CST
  • December 23, 2022         Select applicants will be invited to submit full proposal
  • February 3, 2023              Full pilot project submissions due
  • March 20, 2023                  Awards announced
  • April 3, 2023                        Award start date

Collaborative Pilot Award

Multi-omic profiling of traumatic nerve injury in humans to reveal mechanisms of degeneration, regeneration, and pain

Project: Further information about this project is not available at this time.


Individual Pilot Award:

The last Frontier: small RNA epitranscriptome in Alzheimer’s Disease

Project: Further information about this project is not available at this time.